2025 Update PPIs with DAPT: What Clinicians Need to Know
Join the 2025 update on PPIs with DAPT. Gain confidence in how clinicians balance GI protection with the continuity of antiplatelet therapy.
This session will review the latest clinical guidelines and evidence, define when and how to use PPIs to sustain therapy, and provide a concise 2025 guideline to recommendations and practical prescribing for everyday decision-making.
Key Highlights:
- Explore up-to-date studies on GI protection with DAPT, emphasizing strategies to lower risk, sustain therapy, and improve outcomes.
- Dive deeper into the summary of safety signals evidence on PPIs with DAPT and major adverse cardiac events (MACE).
- Walk through 2025 snapshot of PPIs use with DAPT, outlining current recommendations and practical prescribing considerations.
Insightful Video:
-
Speaker:
Maj. Gen. Assoc. Prof. Nakarin Sansanayudh, M.D., Ph.D.
Cardiologist, Phramongkutklao Hospital
TH-26189
EXP: 05/11/2027
This website is intended for Healthcare Professionals in Thailand.
TH-28626
© AstraZeneca 2026
Our policies
Information
Contact Us
AstraZeneca (Thailand) Ltd.
Asia Centre Building, 19th Floor,
173/20 South Sathorn Road, Thungmahamek,
Sathorn, Bangkok, 10120, Thailand.
Tel: +66 (2) 739 7400, Fax: +66 (2) 739 7497